Tower Research Capital (TRC)’s SteadyMed Ltd STDY Stock Holding History

Tower Research Capital (TRC)’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,842	Closed	-$18K	–	4785
2018 Q3	$18K	Sell	3,842 -519	-12%	-$2.42K	﹤0.01%	2434
2018 Q2	$20K	Buy	+4,361	New	+$17.8K	﹤0.01%	2452
2016 Q3	–	Sell	-357	Closed	-$1K	–	5010
2016 Q2	$1K	Sell	357 -452	-56%	-$1.58K	﹤0.01%	4305
2016 Q1	$2K	Buy	+809	New	+$2.01K	﹤0.01%	3539
2015 Q4	–	Sell	-495	Closed	-$2K	–	5425
2015 Q3	$2K	Sell	495 -1,944	-80%	-$8.86K	﹤0.01%	3485
2015 Q2	$13K	Buy	+2,439	New	+$19.7K	﹤0.01%	2496

Other funds holding STDY

Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Tower Research Capital (TRC)'s STDY Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of SteadyMed Ltd (STDY) in Q4 2018, closing a stake of 3,842 shares — an estimated $18K sold.

Tower Research Capital (TRC) first reported a position in STDY in Q2 2015 and held it in 6 quarters. The position peaked at $20K in Q2 2018. 2 funds tracked by Wall St. Rank hold STDY as of Q4 2018.

Tower Research Capital (TRC) reported no remaining SteadyMed Ltd position as of Q4 2018 after selling out during the quarter.
Tower Research Capital (TRC) sold 3,842 SteadyMed Ltd shares in Q4 2018, an estimated $18K.
Tower Research Capital (TRC) first reported a position in SteadyMed Ltd in Q2 2015 and held it in 6 quarters.
Tower Research Capital (TRC)'s SteadyMed Ltd position peaked at $20K in Q2 2018.
2 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.